Hedgehog signaling: From the cuirass to the heart of pancreatic cancer

Pancreatology

Volumn 12, Issue 4, 2012, Pages 388-393

  Di Marco, Mariacristina ^a   Macchini, Marina ^a   Vecchiarelli, Silvia ^a   Sina, Sokol ^a   Biasco, Guido ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cancer stem cells (CSCs); Exocrine pancreatic cancer; Fibrotic stroma; Hedgehog pathway (HH); Pancreatic stellate cells (PSCs)

Indexed keywords

SONIC HEDGEHOG PROTEIN;

CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EMBRYO DEVELOPMENT; EXOCRINE PANCREAS CANCER; HUMAN; NONHUMAN; PANCREAS; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL;

EID: 84866492650     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2012.06.001     Document Type: Review

References (58)

1. Nüsslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 1980;287:795-801. (Pubitemid 11214475)
2. Heretsch P, Tzagkaroulaki L, Giannis A. Modulators of the Hedgehog signaling pathway. Bioorg Med Chem 2010;18:6613-24.
3. Pasca di Magliano M, Hebrok M. Hedgehog signaling in cancer formation and maintenance. Nat Rev Cancer 2003;3:903-11. (Pubitemid 37500175)
4. Barakat MT, Humke EW, Scott MP. Learning from Jekyll to control Hyde: hedgehog signaling in development and cancer. Trends Mol Med 2010;16: 337-48.
5. Mimeault M, Batra SK. Frequent deregulation in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies. Pharmacol Rev 2010; 62:497-524.
6. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85:841-51. (Pubitemid 26192135)
7. Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009;361:1164-72.
8. Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009;361:1173-8.
9. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003;425:846-51. (Pubitemid 37351469)
10. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, et al. Widespread requirement for hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003;425:846-51. (Pubitemid 37351469)
11. Tniguchi H, Yamamoto H, Akutsu N, Nosho K, Adachi Y, Imai K, et al. Trascriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. J Pathol 2007;213:131-9. (Pubitemid 47612235)
12. Souzaki M, Kubo M, Kai M, Kameda C, Tanaka H, Taguchi T, et al. Hedgehog signaling pathway mediates the progression of non-invasive breast cancer to invasive breast cancer. Cancer Sci 2011;102:373-81.
13. Thomas ZI, Gibson W, Sexton JZ, Aird KM, Ingram SM, Aldrich A, et al. Targeting GLI expression in human inflammatory breast cancer cells enhance apoptosis and attenuates migration. Br J Cancer 2011;104:1575-86.
14. Karlou M, Lu JF, Wu G, Maity S, Tzelepi V, Naone NM, et al. Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b. The Prostate 2012. http:// dx.doi.org/10.1002/pros.22517.
15. Wu JY, Xu XF, Xu L, Niu PQ, Wang F, Hu GY, et al. Cyclopamine blocked the growth of colorectal cancer SW116 cells by modulating some target genes of Gli1 in vitro. Hepatogastroenterology 2011;58:1511-8.
16. Kawahira H, Schell DW, Smith SB, German MS, Hebrok M. Hedgehog signaling regulates expansion of pancreatic epithelial cells. Dev Biol 2005;280:111-21. (Pubitemid 40342746)
17. Jones S, Zhang X, Parson DW, Lin JC, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321:1801-6.
18. Thayer SP, Pasca di Magliano M, Helser PW, Nielsen CM, Roberts DJ, Lauwers GY, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003;425:851-6. (Pubitemid 37355945)
19. Pasca di Magliano M, Sekine S, Ermilov A, Ferris J, Dlugosz AA, Hebrok M. Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev 2006;20:3161-73. (Pubitemid 44790630)
20. Morton JP, Lewis BC. Shh signaling and pancreatic cancer. Cell Cycle 2007; 13: 1553-1557.
21. Morton JP, Mongeau ME, Klimstra DS, Morris JP, Lee YC, Kawaguchi Y, et al. Sonic Hedgehog acts at multiple stages during pancreatic tumorigenesis. PNAS 2007;104:5103-8. (Pubitemid 47186183)
22. Nakashima H, Nakamura M, Yamaguchi H, Yamanaka N, Akiyoshi T, Koga K, et al. Nuclear factor-kB contributes to Hedgehog signalling pathway activation through sonic Hedgehog induction in pancreatic cancer. Cancer Res 2006;66: 7041-9. (Pubitemid 44197680)
23. Yamasaki A, Kameda C, Xu R, Tanaka H, Tasaka T, Chikazawa N, et al. Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh. Cancer Immunol Immunother 2010;59: 675-86.
24. Kasperczyk H, Baumann B, Debatin KM, Fulda. Characterization of sonic Hedgehog as a novel NF-kB target gene that promotes NF-kB-mediated apoptosis resistance and tumor growth in vivo. The FASEB J 2009;23:21-33.
25. Quin CF, Hao K, Tian XD, Xie XH, Yang YM. Combined effects of EGFR and Hedgehog signalling pathway inhibition on the proliferation and apoptosis of pancreatic cancer cells. Oncol Rep 2012. http://dx.doi.org/10.3892/ or.2012.1808.
26. Luo G, Long J, Qiu L, Liu C, Xu J, Yu X. Role of epidermal growth factor receptor expression on patient survival in pancreatic cancer: a meta-analysis. Pancreatology 2011;11:595-600.
27. Eberl M, Klingler S, Mangelberger D, Loipetzberger A, Damhofer H, Zoidi K, et al. Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells. EMBO Mol Med 2012;4:218-33.
28. Mimeault M, Johansson SL, Vankatraman G, Moore E, Henichart JP, Depreux P, et al. Combined targeting of epidermal growth factor receptor and Hedgehog signalling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells. Mol Cancer Ther 2007; 6:967-78. (Pubitemid 46554566)
29. Wang Y, Ding Q, Yen CJ, Xia W, Izzo JG, Lang JY, et al. The crosstalk of mTOR/ S6K1 and Hedgehog pathways. Cancer Cell 2012;20:374-87.
30. Yamazaki M, Nakamura K, Mizukami Y, Ii M, Sasajima J, Sugiyama Y, et al. Sonic Hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cells. Cancer Sci 2008;6: 1131-8. (Pubitemid 351676624)
31. Dunèr S, Lindman JL, Ansari D, Gundewar C, Andersson R. Pancreatic cancer: the role of pancreatic stellate cells in tumor progression. Pancreatology 2010; 10:673-81.
32. Kim EJ, Simeone DM. Advances in pancreatic cancer. Curr Opin Gastroenterol 2011;27:460-6.
33. Kikuta K, Masamune A, Watanabe T, Ariga H, Itoh H, Hamada S, et al. Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells. Biochem Biophys Res Commun 2010;403:380-4.
34. Tian H, Callahan CA, DuPree KJ, Darbonne WC, Ahn CP, Scales SJ, et al. Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. PNAS 2009;106:4254-9.
35. Fendrich V, Oh E, Bang S, Karikari C, Ottenhof N, Bisht S, et al. Ectopic overexpression of sonic Hedgehog (Shh) induces stromale expansion and metaplasia in the adult murine pancreas. Neoplasia 2011;13:923-30.
36. Li X, Ma Q, Xu Q, Liu H, Lei J, Duan W, et al. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway. Cancer Lett 2012.
37. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009;324:1457-61.
38. Garber K. Stromal depletion goes on trial in pancreatic cancer. JNCI 2010;102: 448-50.
39. Volgelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319:525-32.
40. Hurban RH, Goggins M, Parson JL, Kern SE. Progression model for pancreatic cancer. Clin Cancer Res 2000;6:2969-72. (Pubitemid 30637716)
41. Hong SM, Park JY, Hurban RH, Goggins M. Molecular signatures of pancreatic cancer. Arch Pathol Lab Med 2011;135:716-27.
42. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a private hematopoietic cell. Nat Med 1997;3:730-7. (Pubitemid 27298715)
43. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-7.
44. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-8. (Pubitemid 36418143)
45. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct populations of cancer stem cells determinate tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007;1:313-23. (Pubitemid 47355323)
46. Gaviraghi M, Tunici P, Valesin S, Rossi M, Giordano C, Magnoni L, et al. Pancreatic cancer spheres are more than just aggregates of stem marker positive cells. Biosci Rep 2011;31:45-55.
47. Dorado J, Lonardo E, Miranda-Lorenzo I, Heeschen C. Pancreatic cancer stem cells: new insights and perspectives. J Gastroenterol 2011;46:966-73.
48. Lee CJ, Dosch J, Simeone DM. Pancreatic cancer stem cells. J Clin Oncol 2008; 26:2806-12.
49. Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M, et al. Blockade of Hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 2007;67:2187-96. (Pubitemid 46424238)
50. Jimeno A, Feldmann G, Suàrez-Gauthier A, Rasheed Z, Solomon A, Zou GM, et al. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol Cancer Ther 2009;8:310-4.
51. Mueller MT, Hermann PC, Witthauer J, Rubio-Vigueira B, Leicht SF, Huber S, et al. Combined targeted treatment to eliminate tunorigenic cancer stem cells in human pancreatic cancer. Gastroenterology 2009;137:1102-13.
52. Burris HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as firstline therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-13. (Pubitemid 27251144)
53. Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007;25:1960-6. (Pubitemid 46972777)
54. Conroy T, Desseigne F, Ychou M, Bouchè O, Guimbaud R, Bècouarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364:1817-25.
55. Von Hoff D, Ramanathan R, Borad M, Laheru DA, Smith LS, Wood TE, et al. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J Clin Oncol 2011;29:4548-54.
56. Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, et al. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the cancer and leukemia group B (CALGB 80303). J Clin Oncol 2010;28:3617-22.
57. LoRusso PM, Rudin CM, Reddy JC, Tibes R, Weiss GJ, Borad MJ et al. Phase I trial of Hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin Cancer Res; 17: 502-2511.
58. Mo W, Xu X, Xu L, Wang F, Ke A, Wang X, et al. Resveratrol inhibits proliferation and induces apoptosis through the Hedgehog signaling pathway in pancreatic cancer cell. Pancreatology 2011;11:601-9.